Harvest Fund Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.6M | Sell |
104,748
-1,778
| -2% | -$249K | 0.62% | 36 |
|
|
2025
Q4 | $13.1M | Buy |
106,526
+13,385
| +14% | +$1.63M | 0.49% | 41 |
|
|
2025
Q3 | $10.3M | Buy |
93,141
+6,546
| +8% | +$744K | 0.44% | 41 |
|
|
2025
Q2 | $9.6M | Sell |
86,595
-10,659
| -11% | -$1.13M | 0.45% | 41 |
|
|
2025
Q1 | $10.9M | Buy |
97,254
+16,365
| +20% | +$1.69M | 0.54% | 35 |
|
|
2024
Q4 | $7.38M | Buy |
80,889
+23,512
| +41% | +$2.12M | 0.34% | 48 |
|
|
2024
Q3 | $4.81M | Buy |
57,377
+12,076
| +27% | +$921K | 0.29% | 65 |
|
|
2024
Q2 | $3.11M | Buy |
45,301
+8,619
| +23% | +$575K | 0.22% | 66 |
|
|
2024
Q1 | $2.69M | Buy |
36,682
+25,732
| +235% | +$1.98M | 0.24% | 75 |
|
|
2023
Q4 | $887K | Buy |
10,950
+1,145
| +12% | +$89.1K | 0.14% | 82 |
|
|
2023
Q3 | $735K | Buy |
9,805
+3,054
| +45% | +$235K | 0.13% | 91 |
|
|
2023
Q2 | $520K | Buy |
6,751
+916
| +16% | +$73.1K | 0.1% | 101 |
|
|
2023
Q1 | $484K | Buy |
5,835
+1,947
| +50% | +$161K | 0.11% | 102 |
|
|
2022
Q4 | $333K | Buy |
3,888
+2,827
| +266% | +$224K | 0.09% | 144 |
|
|
2022
Q3 | $65K | Buy |
1,061
+823
| +346% | +$51.9K | 0.02% | 372 |
|
|
2022
Q2 | $15K | Hold |
238
| – | – | ﹤0.01% | 570 |
|
|
2022
Q1 | $14K | Hold |
238
| – | – | ﹤0.01% | 620 |
|
|
2021
Q4 | $17K | Hold |
238
| – | – | ﹤0.01% | 630 |
|
|
2021
Q3 | $16K | Buy |
+238
| New | +$16.7K | ﹤0.01% | 623 |
|
|
2020
Q4 | – | Sell |
-170
| Closed | -$10K | – | 610 |
|
|
2020
Q3 | $10K | Sell |
170
-442
| -72% | -$30.7K | ﹤0.01% | 512 |
|
|
2020
Q2 | $46K | Sell |
612
-7,546
| -92% | -$578K | ﹤0.01% | 344 |
|
|
2020
Q1 | $604K | Buy |
8,158
+7,725
| +1,784% | +$534K | 0.07% | 52 |
|
|
2019
Q4 | $28K | Sell |
433
-2,229
| -84% | -$145K | ﹤0.01% | 352 |
|
|
2019
Q3 | $169K | Hold |
2,662
| – | – | 0.02% | 136 |
|
|
2019
Q2 | $180K | Hold |
2,662
| – | – | 0.02% | 125 |
|
|
2019
Q1 | $173K | Buy |
2,662
+964
| +57% | +$64.1K | 0.03% | 129 |
|
|
2018
Q4 | $106K | Sell |
1,698
-1,311
| -44% | -$91.6K | 0.02% | 177 |
|
|
2018
Q3 | $232K | Buy |
3,009
+1,885
| +168% | +$142K | 0.04% | 135 |
|
|
2018
Q2 | $80K | Hold |
1,124
| – | – | 0.01% | 139 |
|
|
2018
Q1 | $84K | Hold |
1,124
| – | – | 0.01% | 133 |
|
|
2017
Q4 | $81K | Hold |
1,124
| – | – | 0.01% | 131 |
|
|
2017
Q3 | $91K | Buy |
+1,124
| New | +$85.9K | 0.01% | 103 |
|
|
2017
Q2 | – | Sell |
-1,014
| Closed | -$69K | – | 218 |
|
|
2017
Q1 | $69K | Hold |
1,014
| – | – | 0.01% | 118 |
|
|
2016
Q4 | $73K | Buy |
+1,014
| New | +$75.4K | 0.02% | 128 |
|
Other funds holding GILD
VCM
VPM
Harvest Fund Management's GILD Position: Q1 2026 in Review
Harvest Fund Management reduced its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, selling an estimated $249K and leaving 104,748 shares worth $14.6M. The position accounts for 0.62% of the portfolio, ranked #36.
Harvest Fund Management first reported a position in GILD in Q4 2016 and has held it in 34 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Harvest Fund Management held 104,748 shares of Gilead Sciences worth $14.6M as of Q1 2026.
- Harvest Fund Management sold 1,778 Gilead Sciences shares in Q1 2026, an estimated $249K.
- Gilead Sciences made up 0.62% of Harvest Fund Management's portfolio in Q1 2026, its #36 holding.
- Harvest Fund Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 34 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.